Literature DB >> 12464726

Antihypertensive effects of hydrolysates of wakame (Undaria pinnatifida) and their angiotensin-I-converting enzyme inhibitory activity.

Minoru Sato1, Takashi Oba, Toshiyasu Yamaguchi, Toshiki Nakano, Takashi Kahara, Katsura Funayama, Akio Kobayashi, Takahisa Nakano.   

Abstract

AIM: The angiotensin-I-converting enzyme (ACE) inhibitory and antihypertensive activities of wakame hydrolysates have been investigated in several studies.
METHODS: Wakame (Undaria pinnatifida) was hydrolyzed using 17 kinds of proteases and the inhibitory activity of the hydrolysates for ACE was measured. Of these hydrolysates 4 with potent ACE inhibitory activity were administered singly and orally to spontaneously hypertensive rats (SHR).
RESULTS: The systolic blood pressure of SHR decreased significantly after single oral administration of protease S 'Amano' and proleather FG-F hydrolysates (10 mg protein/kg body weight). In a long-term feeding experiment, 7-week-old SHR were fed standard chow supplemented with protease S 'Amano'-derived wakame hydrolysates for 10 weeks. In SHR fed the 1 and 0.1% wakame hydrolysates, elevation of systolic blood pressure was still significantly suppressed for 7 weeks.
CONCLUSIONS: The hydrolysates derived from wakame by protease S 'Amano' have a powerful ACE-inhibitory activity (IC(50) = 86 microg protein/ml) and were effective in spite of their slight bitterness as 'physiologically functional food' with antihypertensive activity. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464726     DOI: 10.1159/000066495

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  9 in total

Review 1.  The role of nutrition and nutraceutical supplements in the treatment of hypertension.

Authors:  Mark Houston
Journal:  World J Cardiol       Date:  2014-02-26

2.  Angiotensin-I-Converting Enzyme Inhibitory Activity of Protein Hydrolysates Generated from the Macroalga Laminaria digitata (Hudson) JV Lamouroux 1813.

Authors:  Diane Purcell; Michael A Packer; Maria Hayes
Journal:  Foods       Date:  2022-06-17

Review 3.  Nutrition and nutraceutical supplements for the treatment of hypertension: part III.

Authors:  Mark Houston
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-01       Impact factor: 3.738

4.  Seaweed intake and blood pressure levels in healthy pre-school Japanese children.

Authors:  Keiko Wada; Kozue Nakamura; Yuya Tamai; Michiko Tsuji; Yukari Sahashi; Kaori Watanabe; Sakiko Ohtsuchi; Keiko Yamamoto; Kyoko Ando; Chisato Nagata
Journal:  Nutr J       Date:  2011-08-10       Impact factor: 3.271

Review 5.  Risks and benefits of consuming edible seaweeds.

Authors:  Paul Cherry; Cathal O'Hara; Pamela J Magee; Emeir M McSorley; Philip J Allsopp
Journal:  Nutr Rev       Date:  2019-05-01       Impact factor: 7.110

6.  The effect of Fucus vesiculosus, an edible brown seaweed, upon menstrual cycle length and hormonal status in three pre-menopausal women: a case report.

Authors:  Christine F Skibola
Journal:  BMC Complement Altern Med       Date:  2004-08-04       Impact factor: 3.659

7.  Purification and Identification of Angiotensin I-Converting Enzyme Inhibitory Peptides and the Antihypertensive Effect of Chlorella sorokiniana Protein Hydrolysates.

Authors:  Yu-Hsin Lin; Guan-Wen Chen; Chin Hsi Yeh; Helena Song; Jenn-Shou Tsai
Journal:  Nutrients       Date:  2018-10-01       Impact factor: 5.717

8.  Effect of Dietary Nori (Dried Laver) on Blood Pressure in Young Japanese Children: An Intervention Study.

Authors:  Keiko Wada; Michiko Tsuji; Kozue Nakamura; Shino Oba; Sakiko Nishizawa; Keiko Yamamoto; Kaori Watanabe; Kyoko Ando; Chisato Nagata
Journal:  J Epidemiol       Date:  2020-03-21       Impact factor: 3.211

9.  Seaweed Intake and Risk of Cardiovascular Disease: The Circulatory Risk in Communities Study (CIRCS).

Authors:  Haruka Chichibu; Kazumasa Yamagishi; Rie Kishida; Koutatsu Maruyama; Mina Hayama-Terada; Yuji Shimizu; Isao Muraki; Mitsumasa Umesawa; Renzhe Cui; Hironori Imano; Tetsuya Ohira; Takeshi Tanigawa; Tomoko Sankai; Takeo Okada; Akihiko Kitamura; Masahiko Kiyama; Hiroyasu Iso
Journal:  J Atheroscler Thromb       Date:  2021-02-18       Impact factor: 4.928

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.